EN
HI
Onesource Specialty Pharma Share price
ONESOURCE
1548.5
10.70 (-0.69%)NSE
BSE
Last updated on 17 Aug, 2026 | 09:30 IST
Onesource Specialty Pharma share price chart
Onesource Specialty Pharma Share Key Metrics
Volume
10030.00
Market Cap
17875.57 CR
LTQ@LTP
2@1548.50
ATP
1544.58
Var Margin
20.08 %
Circuit Range
1247.4-1871
Delivery %
56.22 %
Value
1.55 CR
ASM/GSM
No
Market Lot
1
Summary
ONESOURCE stock price is ₹1548.5 as of 17 Aug, 2026. The stock intraday movement has stayed between ₹1533.10 and ₹1564.40, while Onesource Specialty Pharma share price 52 week high low is ₹1057.00 & ₹1925.00.
In terms of trading activity, ONESOURCE share price has recorded a volume of 10,030 shares. The Onesource Specialty Pharma has a market cap of ₹114645801. The stock’s Average Traded Price (ATP) stands at ₹1544.58, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹1548.50.
The Onesource Specialty Pharma upper circuit limit is ₹1871.00 & The Onesource Specialty Pharma lower circuit limit is ₹1247.40, with a Value of ₹1.55 CR. The Delivery Percentage for the day is 56.22%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Onesource Specialty Pharma Resistance and Support
Pivot 1557.07
Resistance
First Resistance
1581.14
Second Resistance
1603.07
Third Resistance
1627.14
Support
First Support
1535.14
Second Support
1511.07
Third Support
1489.14
Onesource Specialty Pharma Shareholding Pattern
View More- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
30.48%
Mutual Fund
12.98%
Insurance
2.86%
Foreign Institutional Investors
19.19%
Domestic Institutional Investors
7.54%
Retail
26.94%
Others
0.01%
Total Promoters
MAR '26
30.48%
JUN '26
30.48%
Onesource Specialty Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-24 | Quarterly Results |
| 2026-05-13 | Audited Results |
| 2026-01-23 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-05 | Audited Results |
Onesource Specialty Pharma News
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Onesource Specialty Pharma reported robust Q1 FY27 results, with revenue growing 37% YoY to ₹449 crore and EBITDA up 39% YoY to ₹123.3 crore. The strong performance was driven by the commercial launch of semaglutide and new MSA contracts.
Jul 24 2026 21:11:37
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management
Onesource Specialty Pharma announced that Ravi Kumar, Global Head – Injectables/Head of Corporate Strategy, Portfolio & SPO, has resigned from his Senior Management Personnel (SMP) position. The resignation is effective July 24, 2026, creating uncertainty in key strategic areas.
Jul 24 2026 19:46:24
Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026
Onesource Specialty Pharma board approved Q1 FY27 financial results. Standalone total income was ₹450.26 cr and profit after tax was ₹51.23 cr. Consolidated total income stood at ₹452.83 cr and profit after tax at ₹25.00 cr. Subsidiary Biolexis faces $136.32 mn legal claim from Prestige Biopharma, pending arbitration.
Jul 24 2026 18:58:44
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Onesource Specialty Pharma will host an Earnings Call on July 25, 2026, at 10:00 AM IST. The call aims to discuss the unaudited financial results for Q1 FY27 (quarter ended June 30, 2026).
Jul 21 2026 12:20:53
Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.
Onesource Specialty Pharma Board will convene on July 24, 2026, to approve its Q1 FY27 financial results. The meeting will also address other agenda items.
Jul 20 2026 18:23:22
Read More
Onesource Specialty Pharma Management
| Name | Position |
|---|---|
| A Trisha | Company Secretary & Compliance Officer |
| Arun Kumar | Chairman |
Onesource Specialty Pharma Similar Stocks
Granules India Ltd.
852.80
-5.60 (0.65%)
Astrazeneca Pharma India Ltd.
7650.00
-103.00 (1.33%)
Caplin Point Laboratories Ltd.
2462.80
-17.70 (0.71%)
Eris Lifesciences Ltd.
1344.20
-14.30 (1.05%)
Poly Medicure Ltd.
1778.40
-7.80 (0.44%)
Cohance Lifesciences Ltd.
440.90
0.25 (0.06%)
Alembic Pharmaceuticals Ltd.
821.50
-9.75 (1.17%)
Natco Pharma Ltd.
892.40
-10.75 (1.19%)
Shilpa Medicare Ltd.
821.55
-0.45 (0.05%)
Dr. Agarwal's Health Care Ltd.
504.45
-2.05 (0.40%)
Onesource Specialty Pharma FAQs
The Buying Price of Onesource Specialty Pharma share is 1548.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Onesource Specialty Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Onesource Specialty Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Onesource Specialty Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Onesource Specialty Pharma shares is 3.04. Useful to assess the stock's value relative to its book value.
To assess Onesource Specialty Pharma’s valuation compare Sector P/E, P/B which are 63.94 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Onesource Specialty Pharma is 17875.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Onesource Specialty Pharma share price is 1925.00 & 1057.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Onesource Specialty Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in ONESOURCE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC